---
title: "Sweet Smell of Roses: Q422 & FY22 US Orthobio Market Recap"
description: "The total Orthobio market is bouncing back and coming through 2022 smelling like a rose for the 2nd year in a row ... #orthobiologics"
---

[Medical Device and Wound Care News and Analysis Blog ](https://blog.smarttrak.com)

# [Sweet Smell of Roses: Q422 & FY22 US Orthobio Market Recap](https://blog.smarttrak.com/sweet-smell-of-roses-q422-fy22-us-orthobio-market-recap)

 Written by [Freddy Buntoum](https://blog.smarttrak.com/author/freddy-buntoum) | 4/20/23 3:35 PM

*<https://app.smarttrak.com/analysis/qs/a56ae0dd6c474611ac10027399c015e6>Total Orthobio market bouncing back and coming through 2022 smelling like a rose for the 2nd year in a row.*

The US Orthobiologics (Orthobio) market performed well during Q4 and for FY22, and the sweet smell of roses seemed to celebrate a rebound to the market, with elective procedure recovery, new product launches, and pull-through from enabling technologies as drivers to growth and positive momentum. Q422 saw growth in all but one segment of the US Orthobio market, which somewhat offset a stronger finish of the quarter and of the year 2022. Nevertheless, Q422 and FY22 closed on high notes.

 

Among the many topics covered in detail in our comprehensive [Q422/FY22 OrthoBio Recap](https://app.smarttrak.com/analysis/qs/a56ae0dd6c474611ac10027399c015e6)* are:

- Complete Q422 Trauma Market Overview and Highlights
- SmartTRAK's Expert Market Analysis and Insights
- All Company News, Revenues, Data, Charts and Shares
- US Bone Replacement 
    - Good Momentum as Spine Rebounds and Products Launch
- US Cartilage Replacement 
    - Procedure Volumes Stabilizing
- US Soft Tissue Replacement   
    - Winter Months More Like a Sunny Day Rose Parade
- US Meniscus Replacement  
    - Growth Dampened by a Non-Blooming Group of Small Players

In addition to the previously mentioned market growth drivers, and as *SmartTRAK* highlighted in its latest trends article, “[*What Lies Ahead for Orthobiologics in 2023 and Beyond*](https://app.smarttrak.com/analysis/qs/8c500c3c84dfc115ac1002b2214c5e44)”,* other contributing factors of growth in 2022 and indicators of future growth in the US Orthobio market, included a tremendous level of M&As, strategic alliances and investments in new technologies. Overall, the US Orthobio market performed above expectations and ...

[Read the entire Q422 Orthobio Market Recap, including *SmartTRAK*'s expert analysis, news, data, charts, company revenues and shares](https://app.smarttrak.com/analysis/qs/a56ae0dd6c474611ac10027399c015e6).*

[*](https://app.smarttrak.com/analysis/qs/33ff3d6f994619f5ac1002b2de723bd0)These links and the complete unedited article can only be viewed by [SmartTRAK](https://www.smarttrak.com/) subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please[ click](https://www.smarttrak.com/contact-us) the button below.

[SmartTRAK](https://www.smarttrak.com/) is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s propriety methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services. If you would like a demo of what SmartTRAK has to offer and see how we can help increase proficiency, improve productivity and reduce costs for your company, just click [here](https://www.smarttrak.com/contact-us).

 

[View full post](https://blog.smarttrak.com/sweet-smell-of-roses-q422-fy22-us-orthobio-market-recap)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Freddy Buntoum"
  },
  "dateModified" : "2023-04-20T15:36:58.154Z",
  "datePublished" : "2023-04-20T15:35:59Z",
  "headline" : "Sweet Smell of Roses: Q422 & FY22 US Orthobio Market Recap",
  "image" : {
    "@type" : "ImageObject",
    "height" : 512,
    "url" : "https://3044256.fs1.hubspotusercontent-na1.net/hubfs/3044256/Q422%20Orthobio%20Recap%20HEADER.png",
    "width" : 1024
  },
  "mainEntityOfPage" : "https://blog.smarttrak.com/sweet-smell-of-roses-q422-fy22-us-orthobio-market-recap",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60.0,
      "url" : "https://cdn2.hubspot.net/hubfs/3044256/SmartTRAK%202.0%20Logo%20Art/SmartTRAK%20Logo%20Email250.png",
      "width" : 187.5
    },
    "name" : "SmartTRAK Life Sciences News and Analysis Blog"
  }
}
```